A genomic-led strategy to anticipate drug safety effects

Brian R. Ferolito, Andrea R. V. R. Horimoto, Kai Gravel-Pucillo, Daniel J. Golden, Hesam Dashti, Claudia Giambartolomei, Danielle Rasooly, Rachael Matty, Liam Gaziano, Yakov Tsepilov, Lauren Costa, Nicole Kosik, Harris Ioannidis, Mohd Karim, Giovanna Winicki, Fiona Hunter, Claudia Langenberg, John C. Whittaker, Unknown, Tianxi Cai, Gina M. Peloso, Barbara Zdrazil, Maya Ghoussaini, Andrew R. Leach, Sumitra Muralidhar, Ines A. Smit, Juan P. Casas, J. Michael Gaziano, Kelly Cho, Alexandre C. Pereira

Open source

DOI
10.1371/journal.pgen.1012211
Published
2026-07-16
Container
PLOS Genetics
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pgen.1012211,
  title = {A genomic-led strategy to anticipate drug safety effects},
  author = {Brian R. Ferolito and Andrea R. V. R. Horimoto and Kai Gravel-Pucillo and Daniel J. Golden and Hesam Dashti and Claudia Giambartolomei and Danielle Rasooly and Rachael Matty and Liam Gaziano and Yakov Tsepilov and Lauren Costa and Nicole Kosik and Harris Ioannidis and Mohd Karim and Giovanna Winicki and Fiona Hunter and Claudia Langenberg and John C. Whittaker and Unknown and Tianxi Cai and Gina M. Peloso and Barbara Zdrazil and Maya Ghoussaini and Andrew R. Leach and Sumitra Muralidhar and Ines A. Smit and Juan P. Casas and J. Michael Gaziano and Kelly Cho and Alexandre C. Pereira},
  year = {2026},
  journal = {PLOS Genetics},
  doi = {10.1371/journal.pgen.1012211},
  url = {https://doi.org/10.1371/journal.pgen.1012211}
}

RIS

TY  - JOUR
TI  - A genomic-led strategy to anticipate drug safety effects
AU  - Brian R. Ferolito
AU  - Andrea R. V. R. Horimoto
AU  - Kai Gravel-Pucillo
AU  - Daniel J. Golden
AU  - Hesam Dashti
AU  - Claudia Giambartolomei
AU  - Danielle Rasooly
AU  - Rachael Matty
AU  - Liam Gaziano
AU  - Yakov Tsepilov
AU  - Lauren Costa
AU  - Nicole Kosik
AU  - Harris Ioannidis
AU  - Mohd Karim
AU  - Giovanna Winicki
AU  - Fiona Hunter
AU  - Claudia Langenberg
AU  - John C. Whittaker
AU  - Unknown
AU  - Tianxi Cai
AU  - Gina M. Peloso
AU  - Barbara Zdrazil
AU  - Maya Ghoussaini
AU  - Andrew R. Leach
AU  - Sumitra Muralidhar
AU  - Ines A. Smit
AU  - Juan P. Casas
AU  - J. Michael Gaziano
AU  - Kelly Cho
AU  - Alexandre C. Pereira
PY  - 2026
JO  - PLOS Genetics
DO  - 10.1371/journal.pgen.1012211
UR  - https://doi.org/10.1371/journal.pgen.1012211
ER  - 

APA

Ferolito, B. R., Horimoto, A. R. V. R., Gravel-Pucillo, K., Golden, D. J., Dashti, H., Giambartolomei, C., Rasooly, D., Matty, R., Gaziano, L., Tsepilov, Y., Costa, L., Kosik, N., Ioannidis, H., Karim, M., Winicki, G., Hunter, F., Langenberg, C., Whittaker, J. C., Unknown, Cai, T., Peloso, G. M., Zdrazil, B., Ghoussaini, M., Leach, A. R., Muralidhar, S., Smit, I. A., Casas, J. P., Gaziano, J. M., Cho, K., & Pereira, A. C. (2026). A genomic-led strategy to anticipate drug safety effects. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1012211

Source records